Coverage
-
November 15, 2012
A New York federal judge on Wednesday threw out an 8-year-old False Claims Act suit from a former Pfizer Inc. medical director claiming the company engaged in off-label marketing of its statin Lipitor, ruling that federal cholesterol guidelines are meant to be advisory rather than restrictive limitations.
1 other articles on this case.
View all »